Regulatory T cells control autoimmunity in vivo by inducing apoptotic depletion of activated pathogenic lymphocytes

被引:73
作者
Madakamutil, LT [1 ]
Maricic, I [1 ]
Sercarz, E [1 ]
Kumar, V [1 ]
机构
[1] La Jolla Inst Allergy & Immunol, Div Immune Regulat, San Diego, CA 92121 USA
关键词
D O I
10.4049/jimmunol.170.6.2985
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Clinical autoimmunity requires both activation of self-reactive T cells as well as a failure-of peripheral tolerance mechanisms. We previously identified one such mechanism that involves regulatory T cells recognizing TCR Vbeta8.2(+) chain-derived peptides in the context of MHC. How this regulation affects the fate of target Vbeta8.2(+) T lymphocytes in vivo that mediate experimental autoimmune encephalomyelitis has remained unknown. The present study using immunoscope and CFSE-labeling analysis demonstrates that the expansion of regulatory CD4 and CD8 T cells in vivo results in apoptotic depletion of the dominant, myelin basic protein-reactive Vbeta8.2(+) T cells, but not subdominant Vbeta8.2(+) T cells. The elimination of only activated T cells by this negative feedback mechanism preserves the remainder of the naive Vbeta8.2(+) T cell repertoire and at the same time results in protection from disease. These studies are the first in clearly elucidating the fate of myelin basic protein-specific encephalitogenic T cells in vivo following regulation.
引用
收藏
页码:2985 / 2992
页数:8
相关论文
共 43 条
[1]   LIMITED HETEROGENEITY OF T-CELL RECEPTORS FROM LYMPHOCYTES MEDIATING AUTOIMMUNE ENCEPHALOMYELITIS ALLOWS SPECIFIC IMMUNE INTERVENTION [J].
ACHAORBEA, H ;
MITCHELL, DJ ;
TIMMERMANN, L ;
WRAITH, DC ;
TAUSCH, GS ;
WALDOR, MK ;
ZAMVIL, SS ;
MCDEVITT, HO ;
STEINMAN, L .
CELL, 1988, 54 (02) :263-273
[2]  
Bonetti B, 1997, J IMMUNOL, V159, P5733
[3]  
BRACIAK TA, 2003, IN PRESS J IMMUNOL
[4]   Failure to suppress the expansion of the activated CD4 T cell population in interferon γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis [J].
Chu, CQ ;
Wittmer, S ;
Dalton, DK .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (01) :123-128
[5]  
Chunduru SK, 1996, J IMMUNOL, V156, P4940
[6]   T-CELL DELETION IN HIGH ANTIGEN DOSE THERAPY OF AUTOIMMUNE ENCEPHALOMYELITIS [J].
CRITCHFIELD, JM ;
RACKE, MK ;
ZUNIGAPFLUCKER, JC ;
CANNELLA, B ;
RAINE, CS ;
GOVERMAN, J ;
LENARDO, MJ .
SCIENCE, 1994, 263 (5150) :1139-1143
[7]   The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD [J].
Delovitch, TL ;
Singh, B .
IMMUNITY, 1997, 7 (06) :727-738
[8]  
Ferber IA, 1996, J IMMUNOL, V156, P5
[9]   Alterations in the spinal cord T cell repertoire during relapsing experimental autoimmune encephalomyelitis [J].
Fritz, RB ;
Wang, XD ;
Zhao, ML .
JOURNAL OF IMMUNOLOGY, 2000, 164 (12) :6662-6668
[10]   Kinetics and thermodynamics of T cell receptor-autoantigen interactions in murine experimental autoimmune encephalomyelitis [J].
Garcia, KC ;
Radu, CG ;
Ho, J ;
Ober, RJ ;
Ward, ES .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (12) :6818-6823